Loading clinical trials...
Loading clinical trials...
Phase II Study of Postoperative, Cardiac-Sparing Proton Radiotherapy for Patients With Stage II/III,Loco-Regional, Non-Metastatic Breast Cancer Requiring Whole Breast or Chest Wall Irradiation With Lymph Node Irradiation
Conditions
Interventions
Proton Radiotherapy
Locations
5
United States
Northwestern Medicine Chicago Proton Center
Warrenville, Illinois, United States
Maryland Proton Treatment Center
Baltimore, Maryland, United States
Princeton ProCure Managment LLC
Somerset, New Jersey, United States
Oklahoma Proton Center
Oklahoma City, Oklahoma, United States
Hampton University Proton Therapy Institute
Hampton, Virginia, United States
Start Date
February 1, 2013
Primary Completion Date
January 1, 2027
Completion Date
January 1, 2032
Last Updated
September 4, 2025
NCT04541381
NCT05468034
NCT03137095
NCT06393374
NCT07040891
NCT07547774
Lead Sponsor
Proton Collaborative Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions